We are live on ! Find out more
ONEM

1Life Healthcare

Delisted

ONEM was delisted on the 21st of February, 2023.

183 hedge funds and large institutions have $2.92B invested in 1Life Healthcare in 2020 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 75 increasing their positions, 32 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $6.25M

134% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 32

110% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 29

21% more funds holding

Funds holding: 151183 (+32)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

5% less capital invested

Capital invested by funds: $3.06B → $2.92B (-$145M)

Holders
183
Holders Change
+32
Holders Change %
+21.19%
% of All Funds
3.69%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
61
Increased
75
Reduced
32
Closed
29
Calls
$15.5M
Puts
$6.25M
Net Calls
+$9.22M
Net Calls Change
+$7M
Name Holding Trade Value Shares
Change
Change in
Stake
CG
1
Carlyle Group
District of Columbia
$585M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$452M +$172M +5,451,887 +52%
Vanguard Group
3
Vanguard Group
Pennsylvania
$185M +$119M +3,756,643 +135%
OMC
4
Oak Management Corp
Connecticut
$171M -$189M -5,996,439 -50%
BlackRock
5
BlackRock
New York
$170M +$141M +4,455,397 +287%
Fidelity International
6
Fidelity International
Bermuda
$143M +$24.6M +777,744 +18%
GGHC
7
Gilder Gagnon Howe & Co
New York
$118M +$54.6M +1,729,761 +71%
MC
8
Maverick Capital
Texas
$112M +$15.8M +500,000 +14%
RG
9
Redmile Group
California
$94.9M +$10.5M +334,010 +11%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$68.9M +$8.49M +268,962 +12%
CS
11
Credit Suisse
Switzerland
$48.9M +$22.3M +707,477 +70%
1WCM
12
12 West Capital Management
New York
$39.7M +$44.2M +1,399,796 New
State Street
13
State Street
Massachusetts
$39.4M +$31.1M +985,523 +243%
WRF
14
Waddell & Reed Financial
Kansas
$37M +$11.9M +377,102 +41%
Goldman Sachs
15
Goldman Sachs
New York
$34.5M +$34.8M +1,100,672 +960%
SPPAM
16
Summit Partners Public Asset Management
Massachusetts
$34.3M +$25.6M +810,464 +203%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$32.3M +$21.9M +692,093 +155%
Northern Trust
18
Northern Trust
Illinois
$25.5M +$18.3M +580,113 +182%
Invesco
19
Invesco
Georgia
$24.8M +$6.9M +218,509 +33%
N
20
Nuveen
North Carolina
$21.6M +$12.9M +408,601 +116%
Franklin Resources
21
Franklin Resources
California
$20.8M +$23.1M +732,689 New
Norges Bank
22
Norges Bank
Norway
$19.5M +$13.1M +415,502 +152%
Morgan Stanley
23
Morgan Stanley
New York
$19.1M +$12.7M +401,793 +148%
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$18.8M +$13M +411,302 +162%
Charles Schwab
25
Charles Schwab
California
$18M +$12.7M +401,591 +174%

ONEM Hedge Fund Activity: Q3 2020 in Review

183 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in 1Life Healthcare (ONEM) for Q3 2020, worth a combined $2.92B — down 4.7% from $3.06B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new ONEM positions and 29 closed out — a net gain of 32 holders — while 75 added to existing stakes and 32 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $172M. The largest seller was Alphabet Inc, exiting entirely with an estimated $225M sold.

  • 183 institutional investors held 1Life Healthcare (ONEM) as of Q3 2020, up from 151 in Q2 2020.
  • Funds reported $2.92B of 1Life Healthcare stock for Q3 2020, down 4.7% quarter-over-quarter.
  • 61 funds opened new 1Life Healthcare positions in Q3 2020 and 29 closed out, a net change of +32 holders.
  • The largest 1Life Healthcare buyer in Q3 2020 was Fidelity Investments, an estimated $172M added.
  • The largest 1Life Healthcare seller in Q3 2020 was Alphabet Inc, an estimated $225M sold.

Based on aggregated 13F filings for Q3 2020.